CHORUS EPSTEIN-BARR EARLY ANTIGEN IGM - COFEPRIS Registration 1794R2019 SSA
Access comprehensive regulatory information for CHORUS EPSTEIN-BARR EARLY ANTIGEN IGM (CHORUS EPSTEIN-BARR EARLY ANTIGEN IGM) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1794R2019 SSA and manufactured by GRIFOLS MÉXICO, S.A. DE C.V.. The device was registered on September 02, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS IGM ANTI-EARLY ANTIGEN DEL VIRUS DE EPSTEIN-BARR EN SUERO HUMANO CON DISPOSITIVO DESECHABLE APLICADO A LOS EQUIPOS CHORUS.
FOR THE QUALITATIVE DETERMINATION OF IGM ANTI-EARLY ANTIGEN ANTIBODIES OF EPSTEIN-BARR VIRUS IN HUMAN SERUM WITH DISPOSABLE DEVICE APPLIED TO CHORUS EQUIPMENT.